Yuliang Feng,Wei Huang,Christian Paul,Xingguo Liu,Sakthivel Sadayappan,Yigang Wang,Siim Pauklin
Abstract:Abstract Metabolic function and energy production in eukaryotic cells are regulated by mitochondria, which have been recognized as the intracellular ‘powerhouses’ of eukaryotic cells for their regulation of cellular homeostasis. Mitochondrial function is important not only in normal developmental and physiological processes, but also in a variety of human pathologies, including cardiac diseases. An emerging topic in the field of cardiovascular medicine is the implication of mitochondrial nucleoid for metabolic reprogramming. This review describes the linear/3D architecture of the mitochondrial nucleoid (e.g., highly organized protein-DNA structure of nucleoid) and how it is regulated by a variety of factors, such as noncoding RNA and its associated R-loop, for metabolic reprogramming in cardiac diseases. In addition, we highlight many of the presently unsolved questions regarding cardiac metabolism in terms of bidirectional signaling of mitochondrial nucleoid and 3D chromatin structure in the nucleus. In particular, we explore novel techniques to dissect the 3D structure of mitochondrial nucleoid and propose new insights into the mitochondrial retrograde signaling, and how it regulates the nuclear (3D) chromatin structures in mitochondrial diseases.
What problem does this paper attempt to address?
The paper primarily explores the role of mitochondrial nucleoids in cardiac homeostasis, particularly the bidirectional signaling mechanisms in heart diseases. Mitochondria are not only the cell's powerhouses but also participate in a variety of human pathological processes, including heart diseases. The research focuses on the linear/three-dimensional structure of mitochondrial nucleoids and how they regulate metabolic reprogramming through non-coding RNA and associated R-loops. Moreover, the paper discusses the unresolved mysteries between mitochondrial nucleoids and the nuclear 3D chromatin structure, especially in terms of cardiac metabolism. Specifically, the article explores novel techniques to resolve the three-dimensional structure of mitochondrial nucleoids and presents new insights into mitochondrial retrograde signaling, as well as how it regulates the nuclear (3D) chromatin structure in mitochondrial diseases.
The abstract section first emphasizes the central role of mitochondria in metabolic functions and energy production, noting their importance not only for normal development and physiological processes but also in relation to various human diseases, especially heart diseases. Subsequently, the article provides a detailed introduction to the structural features of mitochondrial nucleoids, including highly organized protein-DNA structures, and how these structures are regulated by factors such as non-coding RNA and R-loops to achieve metabolic reprogramming. The paper also highlights the many unresolved mysteries regarding the bidirectional signaling between mitochondrial nucleoids and nuclear 3D chromatin structures in cardiac metabolism, proposes new techniques for analyzing the three-dimensional structure of mitochondrial nucleoids, and discusses the impact of mitochondrial retrograde signaling on the regulation of nuclear chromatin structure.
Keywords include "mitochondrial nucleoids," "three-dimensional genome organization," "metabolic reprogramming," and "cardiovascular diseases." The paper also lists several abbreviations, covering a wide range of terms from molecular biology and cell biology to clinical medicine, reflecting the depth and breadth of the research.
The introduction further elaborates on how cells adapt to environmental changes and adjust energy metabolism through metabolic reprogramming, emphasizing the role of mitochondria as the center of cellular energy metabolism, particularly in the heart. The article also discusses the critical role of mitochondria in heart development and differentiation, as well as the relationship between mitochondrial dysfunction and various heart diseases, such as heart failure. Finally, the paper mentions the complexity of mitochondrial genome transcriptional regulation, especially the mechanisms regulated by mitochondria-derived non-coding RNA transferred from the nucleus, and how they coordinate mitochondrial transcription in cardiac metabolic reprogramming. In addition, the article reviews mitochondrial retrograde signaling, exploring its potential impact on nuclear chromatin structure (such as three-dimensional chromatin topology) and its significance for mitochondrial diseases that typically present with cardiomyopathy as an initial symptom.